Matthias Steiert has extensive experience with nano-scale systems both for the development of drug delivery systems and diagnostics particularly in the areas of cancer and antimicrobial disease diagnostics. He is also a consultant for various companies involved in nanotechnological applications and is cofounder of Afaf Translations LLC, a scientific language service provider. Previously, he was co-founder of Los Gatos Pharmaceuticals and before held a position as Senior Director of R&D at Matrix Sensors Inc. and prior to that 10 years of senior-level research positions at several biotechnology companies in the fields of nanotechnology, drug development, diagnostics, and blood safety in the San Francisco Bay Area. Earlier in his career, Matthias was Senior Scientist at GlaxoSmithKline (Italy), a research fellow at the National Institute of Health and Environment (The Netherlands), and a consultant for the World Health Organization. He received his postdoctoral training from the University of California, Berkeley. Matthias holds a degree in plant physiology from the University of Freiburg (Germany) and obtained his Ph.D. in biochemistry from the University of Basel (Switzerland).